Jacques Nienaber should have been gradually assembling his preferred Bok XV in his mind by now.Filling the likely Pieter-Steph du Toit gap at blindside flank would have been a critical issue.Sale-based Jean-Luc du Preez might have been in line for a recall after a two-year absenceThis week, new Springbok head coach Jacques Nienaber should have…
Pieter-Steph du Toit (Gallo Images) Lloyd Burnard - Sport24 Pieter-Steph du Toit exited his Stormers contract on Thursday night with the intention of staying at the union. Now, that might not happen.Sport24 understands that the Stormers were on Saturday working on a new agreement with the 2019 World Rugby Player of the Year. As is stands, though,…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f